Is walking capacity in subjects with multiple sclerosis primarily related to muscle oxidative capacity or maximal muscle strength? A pilot study

Dominique Hansen, Peter Feys, Inez Wens, Bert O Eijnde, Dominique Hansen, Peter Feys, Inez Wens, Bert O Eijnde

Abstract

Background and Purpose. Walking capacity is reduced in subjects with multiple sclerosis (MS). To develop effective exercise interventions to enhance walking capacity, it is important to determine the impact of factors, modifiable by exercise intervention (maximal muscle strength versus muscle oxidative capacity), on walking capacity. The purpose of this pilot study is to discriminate between the impact of maximal muscle strength versus muscle oxidative capacity on walking capacity in subjects with MS. Methods. From 24 patients with MS, muscle oxidative capacity was determined by calculation of exercise-onset oxygen uptake kinetics (mean response time) during submaximal exercise bouts. Maximal muscle strength (isometric knee extension and flexion peak torque) was assessed on dynamometer. All subjects completed a 6-minute walking test. Relationships between walking capacity (as a percentage of normal value) and muscle strength (of knee flexors and extensors) versus muscle oxidative capacity were assessed in multivariate regression analyses. Results. The expanded disability status score (EDSS) showed a significant univariate correlation (r = -0.70, P < 0.004) with walking capacity. In multivariate regression analyses, EDSS and mean response time, but not muscle strength, were independently related to walking capacity (P < 0.05). Conclusions. Walking distance is, next to disability level and not taking neurologic symptoms/deficits into account, primarily related to muscle oxidative capacity in subjects with MS. Additional study is needed to further examine/verify these findings.

Figures

Figure 1
Figure 1
Study flowchart.

References

    1. Romberg A, Virtanen A, Aunola S, Karppi S-L, Karanko H, Ruutiainen J. Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis. Multiple Sclerosis. 2004;10(2):212–218.
    1. Savci S, Inal-Ince D, Arikan H, et al. Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disability and Rehabilitation. 2005;27(22):1365–1371.
    1. Chetta A, Rampello A, Marangio E, et al. Cardiorespiratory response to walk in multiple sclerosis patients. Respiratory Medicine. 2004;98(6):522–529.
    1. Paltamaa J, Sarasoja T, Leskinen E, Wikström J, Mälkiä E. Measuring deterioration in international classification of functioning domains of people with multiple sclerosis who are ambulatory. Physical Therapy. 2008;88(2):176–190.
    1. Gijbels D, Alders G, Van Hoof E, et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Multiple Sclerosis. 2010;16(5):618–626.
    1. Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabilitation and Neural Repair. 2009;23(2):108–116.
    1. Broekmans T, Gijbels D, Eijnde BO, et al. The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis. Multiple Sclerosis. 2012;19(1):112–119.
    1. Wetzel JL, Fry DK, Pfalzer LA. Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiotherapy Canada. 2011;63(2):166–180.
    1. Thoumie P, Lamotte D, Cantalloube S, Faucher M, Amarenco G. Motor determinants of gait in 100 ambulatory patients with multiple sclerosis. Multiple Sclerosis. 2005;11(4):485–491.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine. 2002;166(1):111–117.
    1. Kumleh HH, Riazi GH, Houshmand M, Sanati MH, Gharagozli K, Shafa M. Complex I deficiency in Persian multiple sclerosis patients. Journal of the Neurological Sciences. 2006;243(1-2):65–69.
    1. Mao P, Reddy PH. Is multiple sclerosis a mitochondrial disease? Biochimica et Biophysica Acta. 2010;1802(1):66–79.
    1. Kent-Braun JA, Ng AV, Castro M, et al. Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. Journal of Applied Physiology. 1997;83(6):1998–2004.
    1. Grassi B, Porcelli S, Salvadego D, Zoladz JA. Slow VO2 kinetics during moderate-intensity exercise as markers of lower metabolic stability and lower exercise tolerance. European Journal of Applied Physiology. 2011;111(3):345–355.
    1. Spencer MD, Murias JM, Lamb HP, Kowalchuk JM, Paterson DH. Are the parameters of VO2, heart rate and muscle deoxygenation kinetics affected by serial moderate-intensity exercise transitions in a single day? European Journal of Applied Physiology. 2011;111(4):591–600.
    1. Barstow TJ, Jones AM, Nguyen PH, Casaburi R. Influence of muscle fiber type and pedal frequency on oxygen uptake kinetics of heavy exercise. Journal of Applied Physiology. 1996;81(4):1642–1650.
    1. Hughson RL. Oxygen uptake kinetics: historical perspective and future directions. Applied Physiology, Nutrition and Metabolism. 2009;34(5):840–850.
    1. Grassi B. Oxygen uptake kinetics: why are they so slow? And what do they tell us? Journal of Physiology and Pharmacology. 2006;57(supplement 10):53–65.
    1. Hansen D, Wens I, Kosten L, et al. Slowed exercise-onset VO2 kinetics during submaximal endurance exercise in subjects with multiple sclerosis. Neurorehabilitation and Neural Repair. 2013;27(1):87–95.
    1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983;33(11):1444–1452.
    1. Glickman SG, Marn CS, Supiano MA, Dengel DR. Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. Journal of Applied Physiology. 2004;97(2):509–514.
    1. van der Ploeg HP, Streppel KRM, van der Beek AJ, van der Woude LHV, Vollenbroek-Hutten M, van Mechelen W. The physical activity scale for individuals with physical disabilities: test-retest reliability and comparison with an accelerometer. Journal of Physical Activity & Health. 2007;4(1):96–100.
    1. Washburn RA, Zhu W, McAuley E, Frogley M, Figoni SF. The physical activity scale for individuals with physical disabilities: development and evaluation. Archives of Physical Medicine and Rehabilitation. 2002;83(2):193–200.
    1. Carter H, Jones AM, Barstow TJ, Burnley M, Williams CA, Doust JH. Oxygen uptake kinetics in treadmill running and cycle ergometry: a comparison. Journal of Applied Physiology. 2000;89(3):899–907.
    1. Dalgas U, Kjolhede T, Gijbels D, et al. Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis. Journal of Rehabilitation Medicine. 2013
    1. Baldari C, Bonavolontà V, Emerenziani GP, Gallotta MC, Guidetti L, Silva AJ. Accuracy, reliability, linearity of Accutrend and Lactate Pro versus EBIO plus analyzer. European Journal of Applied Physiology. 2009;107(1):105–111.
    1. Jones NL, Makrides L, Hitchcock C. Normal standards for an incremental progressive cycle ergometer test. American Review of Respiratory Disease. 1985;131(5):700–708.
    1. Gijbels D, Eijnde BO, Feys P. Comparison of the 2- and 6-minute walk test in multiple sclerosis. Multiple Sclerosis. 2011;17(10):1269–1272.
    1. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Multiple Sclerosis. 2008;14(3):383–390.
    1. Enrichi PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. American Journal of Respiratory and Critical Care Medicine. 1998;158(5):1384–1387.
    1. Kjolhede T, Vissing K, Dalgas U. Multiple sclerosis and progressive resistance training: a systematic review. Multiple Sclerosis. 2012;18(9):1215–1228.
    1. Swinnen E, Beckwée D, Pinte D, et al. Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review. Multiple Sclerosis International. 2012;2012:15 pages.240274
    1. Rodgers MM, Mulcare JA, King DL, Mathews T, Gupta SC, Glaser RM. Gait characteristics of individuals with multiple sclerosis before and after a 6-month aerobic training program. Journal of Rehabilitation Research and Development. 1999;36(3):183–188.
    1. Kileff J, Ashburn A. A pilot study of the effect of aerobic exercise on people with moderated disability multiple sclerosis. Clinical Rehabilitation. 2005;19(2):165–169.
    1. Rampello A, Franceschini M, Piepoli M, et al. Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Physical Therapy. 2007;87(5):545–555.
    1. Dettmers C, Sulzmann M, Ruchay-Plössl A, Gütler R, Vieten M. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurologica Scandinavica. 2009;120(4):251–257.
    1. Sabapathy NM, Minahan CL, Turner GT, Broadley SA. Comparing endurance- and resistance-exercise training in people with multiple sclerosis: a randomized pilot study. Clinical Rehabilitation. 2011;25(1):14–24.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel